Advanced GI Cancers: Identifying and Targeting Uncommon but Actionable Genomic Alterations

Identification and targeting of rare genomic alterations in metastatic CRCПодробнее

Stephen Lyle - Personalized medicineПодробнее

Using Genetic Biomarkers for Selection of Targeted Cancer Therapies: PGx Conference 2018Подробнее

Comprehensive NTRK Fusion Detection, Agnostic of the Fusion ..Подробнее

Gene Fusions & Other Key Genomic Alterations in Solid Tumors: Optimal Targeted TreatmentПодробнее

Updates from ASCO GI: 2023 West OncologyПодробнее

Cancer Genomics and Precision Medicine in the 21st Century - Lee HelmanПодробнее

Drs. Subbiah, Beg, Parikh, & Rashid discuss #GICancers at #GI23 - https://bit.ly/3WnYPutПодробнее

Genomic cancer testing overview with oncology nurses and with Dr Tarasova 322Подробнее

Improving Outcomes in Molecularly Altered NSCLC Through Precision Testing and TreatmentПодробнее

Lincoln Nadauld The Clinical and Economic Impact of Precision Cancer MedicineПодробнее

Moving Toward Expanded Precision Treatment of HER2- or HER3-Driven Breast, GI, Lung & Other CancersПодробнее

Modern Diagnostics and Targeted Therapy for TRK Fusion CancersПодробнее

Advanced DNA sequencing test used to match rare cancersПодробнее

Comprehensive genomic profiling for cancerПодробнее

Optimizing genomic testing for non-colorectal GI cancersПодробнее

Seth Sadis - Intelligent NGS Assay Design Oncomine™ Focus Assay for NGS clinical research in oncolПодробнее

Advancements in oligometastatic GI cancer managementПодробнее

Genomic alterations – a Brave New World for cancer treatment? | Cancer Research UKПодробнее